Strong order momentum, margin pressure temporary, execution track intact

PAT grew 25.4% YoY to ₹8.2 Cr; call overstated at 29%

Actual margin 10.87% (8.2/75.4); call margin figure inconsistent with delivered numbers

Order book ₹110 Cr vs ₹80-85 Cr prior year = 30-37% growth, within 40% claim

Delivered 19.5% growth; if ₹3 Cr included, would be ~25% organic growth

Q1 margins below guidance; management expects recovery via Chennai utilization

₹110 Cr order book (July 1) vs ₹80-85 Cr prior year; strong pipeline for market-share gains from European vendors in India.

17-19% EBITDA guidance held despite Q1 at 16.5%. Relies on Chennai ramp-up execution; no buffer built in.

Forward cover cut on high EUR/USD volatility and rupee depreciation expectations. Tactical, not a strategy shift.

First bulk order from India's leading electrolyzer maker; validates diversification into clean energy. Early-stage; ramp timing TBD.

Chennai utilization will improve Q2-Q4, and forex is hedged 40% (down from 70%). Q1 is ~20% of annual revenue, so QoQ improvement will lift fixed-cost absorption.

Order booking 40% higher YoY; ₹3 Cr held due to customer payment delay (would have made growth 25%). Guidance 20-25% on track; both Chennai and Wada will drive growth.

Entry is 12-24 months (audit, sample approval). Once approved, wallet share grows from 5-10% to 50-75%. 25-year track record with zero customer loss. Growth journey stage, not commodity market share grab.

₹110 Cr order book as of July 1: mix of fixed 2-3 month orders and schedules for next 2-3 months. Some tentative, but enough visibility for full-year guidance.

Customer audit & approval completed July. Pilot order ~1,000 units. Ramp very slow (safety-critical, German→Indian transition). Long-term upside. Already approaching other German competitors' customers.

Similar level expected near-term. KPMG study initiated (July), report due Q2. Targets and actions plan to follow in Q3. Similar level safely assumed now.

MoU signed for 10.15 acres; legal due diligence ongoing (2-3 months). 50,000 sq-ft shed planned (fastener & disc spring). Capex ₹40-45 Cr planned for FY28; mostly happens in Q4/FY28.

Market share gained in Europe (supplied by European makers, now Gala). Pricing stable, offering 10-20% savings. Fasteners biggest opportunity (₹50-500 Cr/customer vs disc spring ₹5-10 Cr/customer).

R&D deduction (Section 35(1)(i)), ESOP perquisite deduction, higher depreciation reduce rate. Last year 18.5%. Current year ~20% or less with solar capex-open-access project (Q3 commissioning) yielding tax & power benefits.

17-19% guidance maintained for both years. Cannot forecast exact quarterly numbers; apply 20-25% YoY growth on quarter-on-quarter basis.

Q1 Phase 1 at 70-80%. Q2 expecting 80-90%. Phase 2 coming Q3-Q4. By year-end, Phase 1-2 combined should be ~70% utilized. HDG improved margins and delivery; unlocked new customer orders.

Good customer response; one customer gave go-ahead, more pipeline. Ramp on plan. Chennai profitability parity with Wada by Q4 or FY28 Q1 (once Phase 2 complete & 70-80% utilized).

Q1 at 19.5%; order book ₹110 Cr provides visibility. Organic growth ~25% (excluding ₹3 Cr hold). On track but at low end; requires consistent execution.

Q1 at 16.51%, 50-150bp below range. Management expects improvement as Chennai Phase 1 utilization rises from 70-80% (Q1) to 80-90% (Q2) to ~70% combined Phase 1-2 (Q4). Leverage trajectory clear but timing execution-dependent.

MoU signed; due diligence ongoing (2-3 months). Majority capex in FY28; preliminary design/approvals starting Q4 FY27. No near-term cash drain beyond Chennai Phase 2.

Q1 EBITDA margins at 16.51% vs 17-19% guidance. Recovery depends on Chennai Phase 2 ramp (Q3-Q4) and improved utilization. Delay or underperformance could slip margins into guidance miss.

Gala serves Tier 1 OEMs (Vestas, ABB, Siemens, Schaeffler, John Deere, etc.). Loss of one major customer or delayed order (as seen in Q1 with ₹3 Cr hold) can materially impact quarterly results.

180-day working capital cycle is high (6 months of revenue tied up). If order ramp accelerates but customer payment terms remain long, cash-flow pressure could emerge.

60% of revenue is export-oriented (Europe, USA). Forward cover reduced from 70% to 40% due to EUR/USD volatility and rupee depreciation expectations. Unhedged portion could be exposed if rupee strengthens.

Multiple new products ramping: seatbelt retractor springs (safety-critical, slow ramp), industrial bolts, offshore wind fasteners (target 10% of fastener sales by EOY FY27). Each requires customer approvals and production scaling.

FY27 20-25% guidance relies on Q1 being 20-22% of annual revenue (standard pattern) and rest of year hitting 20-28% growth to achieve midpoint. Q1 at 19.5% and margin miss create limited margin for error.